Sandbox reserved 1651
From Proteopedia
(Difference between revisions)
Line 6: | Line 6: | ||
== Structure == | == Structure == | ||
- | === The hcis-PT subunits === | ||
+ | === The hcis-PT subunits === | ||
The hcis-PT is a tetramer formed by assembling a dimer of heterodimers. The hcis-PT is composed of two catalytically active [https://en.wikipedia.org/wiki/Dehydrodolichyl_diphosphate_synthase dehydrodolichyl diphosphate synthases] (<scene name='87/872232/Subunit_dhdds/1'>DHDDS</scene>) and the Nogo-B receptor (<scene name='87/872232/Ngbr_aliases_nus1/1'>NgBR</scene>). The NgBR can be divided into two domains: a C-terminal pseudo [https://en.wikipedia.org/wiki/Prenyltransferase prenyltransferase] domain that interacts with DHDDS and an N-terminal transmembrane domain that is anchored in the endoplasmic reticulum. The NgBR C-terminus encompasses the RxG motif which might have an important role in hcis-PT activity and which is not present in NUS1 ([[6jcn]]), the yeast homolog of NgBR. The structure of DHDDS can be divided into three domains: a <scene name='87/872232/Dhdds_ctd/1'>C-terminal domain</scene> (residues 251–333), a <scene name='87/872232/Dhdds_n-terminal_domain/1'>N-terminal domain</scene> (residues 1–26) and a <scene name='87/872232/Dhdds_catalytic_domain/1'>canonical catalytic cis-PT homology domain</scene> (residues 27–250). The cis-PT homology domain heterodimerizes with NgBR. The tetramer is formed by heterotypic interactions of the "turn" region with NgBR and by homotypic interactions between DHDDS. The whole complex is directed towards the cytosol. | The hcis-PT is a tetramer formed by assembling a dimer of heterodimers. The hcis-PT is composed of two catalytically active [https://en.wikipedia.org/wiki/Dehydrodolichyl_diphosphate_synthase dehydrodolichyl diphosphate synthases] (<scene name='87/872232/Subunit_dhdds/1'>DHDDS</scene>) and the Nogo-B receptor (<scene name='87/872232/Ngbr_aliases_nus1/1'>NgBR</scene>). The NgBR can be divided into two domains: a C-terminal pseudo [https://en.wikipedia.org/wiki/Prenyltransferase prenyltransferase] domain that interacts with DHDDS and an N-terminal transmembrane domain that is anchored in the endoplasmic reticulum. The NgBR C-terminus encompasses the RxG motif which might have an important role in hcis-PT activity and which is not present in NUS1 ([[6jcn]]), the yeast homolog of NgBR. The structure of DHDDS can be divided into three domains: a <scene name='87/872232/Dhdds_ctd/1'>C-terminal domain</scene> (residues 251–333), a <scene name='87/872232/Dhdds_n-terminal_domain/1'>N-terminal domain</scene> (residues 1–26) and a <scene name='87/872232/Dhdds_catalytic_domain/1'>canonical catalytic cis-PT homology domain</scene> (residues 27–250). The cis-PT homology domain heterodimerizes with NgBR. The tetramer is formed by heterotypic interactions of the "turn" region with NgBR and by homotypic interactions between DHDDS. The whole complex is directed towards the cytosol. | ||
Line 20: | Line 20: | ||
The catalytical domain of DHDDS is homologous to [[undecaprenyl pyrophosphate synthase]] (UPPS) with 2 α-helices and four β-strands within each monomer. The active site is formed by a <scene name='87/872232/Superficial_polar_region/1'>superficial polar region</scene> stabilizing the interaction between IPP and a <scene name='87/872232/Hydrophobic_tunnel/1'>deep hydrophobic tunnel</scene> which accommodate the elongating carbon chain. In the active-site, there are two substrate-binding sites, a S1 and a S2 site. The <scene name='87/872232/S1_site/2'>S1 site</scene> binds the initiatory substrate FPP. It also interacts with Mg<sup>2+</sup> ions which are crucial for IPP hydrolysis during the condensation reaction. The Mg<sup>2+</sup> is stabilized and <scene name='87/872232/Octahedrally_coordinated_mg/3'>octahedrally coordinated</scene> by three surrounding water molecules, two oxygens of the pyrophosphate and one carboxylate oxygen of D34, which provides the biological protein function. <scene name='87/872232/S2_site/1'>S2 site</scene> binds the IPP molecule which will be used for chain elongation. The C-terminus of NgBR (RxG) is directly involved in forming the superficial polar region and enable the formation of S1 and S2. In fact, at the S1 site, we have two polar interaction networks between NgBR and DHDDS. At <scene name='87/872232/S2_site/1'>S2 site</scene>, the backbone nitrogen atoms directly coordinate the phosphate molecule. | The catalytical domain of DHDDS is homologous to [[undecaprenyl pyrophosphate synthase]] (UPPS) with 2 α-helices and four β-strands within each monomer. The active site is formed by a <scene name='87/872232/Superficial_polar_region/1'>superficial polar region</scene> stabilizing the interaction between IPP and a <scene name='87/872232/Hydrophobic_tunnel/1'>deep hydrophobic tunnel</scene> which accommodate the elongating carbon chain. In the active-site, there are two substrate-binding sites, a S1 and a S2 site. The <scene name='87/872232/S1_site/2'>S1 site</scene> binds the initiatory substrate FPP. It also interacts with Mg<sup>2+</sup> ions which are crucial for IPP hydrolysis during the condensation reaction. The Mg<sup>2+</sup> is stabilized and <scene name='87/872232/Octahedrally_coordinated_mg/3'>octahedrally coordinated</scene> by three surrounding water molecules, two oxygens of the pyrophosphate and one carboxylate oxygen of D34, which provides the biological protein function. <scene name='87/872232/S2_site/1'>S2 site</scene> binds the IPP molecule which will be used for chain elongation. The C-terminus of NgBR (RxG) is directly involved in forming the superficial polar region and enable the formation of S1 and S2. In fact, at the S1 site, we have two polar interaction networks between NgBR and DHDDS. At <scene name='87/872232/S2_site/1'>S2 site</scene>, the backbone nitrogen atoms directly coordinate the phosphate molecule. | ||
- | |||
=== The elongation reaction in the hydrophobic active-site tunnel === | === The elongation reaction in the hydrophobic active-site tunnel === | ||
Line 26: | Line 25: | ||
The cis-PT catalyze the chain elongation of FPP by successive head-to-tail condensation with a specific number of IPP to form linear lipids with designated chain lengths. The reaction is as follows: | The cis-PT catalyze the chain elongation of FPP by successive head-to-tail condensation with a specific number of IPP to form linear lipids with designated chain lengths. The reaction is as follows: | ||
IPP headgroups are bound to the enzyme at the superficial polar region while the carbon chains point toward the <scene name='87/872232/Hydrophobic_tunnel/1'>deep hydrophobic tunnel</scene>. First, the pyrophosphate group (FPP) of the initiatory substrate, which interacts with a Mg<sup>2+</sup> ion, is hydrolyzed at the <scene name='87/872232/S1_site/2'>S1 site</scene>. Then, the condensation of remaining carbon with the IPP from S2 site follows. The elongated products translocate to the S1 so the carbon chain goes into the hydrophobic tunnel of the active site. At the end, a new IPP molecule binds to the S2 site and the cycle is repeated until the active site can no longer accommodate the long chain isoprenoid. | IPP headgroups are bound to the enzyme at the superficial polar region while the carbon chains point toward the <scene name='87/872232/Hydrophobic_tunnel/1'>deep hydrophobic tunnel</scene>. First, the pyrophosphate group (FPP) of the initiatory substrate, which interacts with a Mg<sup>2+</sup> ion, is hydrolyzed at the <scene name='87/872232/S1_site/2'>S1 site</scene>. Then, the condensation of remaining carbon with the IPP from S2 site follows. The elongated products translocate to the S1 so the carbon chain goes into the hydrophobic tunnel of the active site. At the end, a new IPP molecule binds to the S2 site and the cycle is repeated until the active site can no longer accommodate the long chain isoprenoid. | ||
- | |||
=== Regulation of the product length === | === Regulation of the product length === | ||
Line 35: | Line 33: | ||
== Functional importance and link to human health == | == Functional importance and link to human health == | ||
+ | |||
=== Product of the N-glycosylation === | === Product of the N-glycosylation === | ||
The [https://en.wikipedia.org/wiki/N-linked_glycosylation N-glycosylation]is a post-translational modification realized in the endoplasmic reticulum of the cell. This process consist in linking a glycan to a protein, which provide the biological protein fonction and folding. The hcis-PT produce DHDD (dehydrodolichyl diphosphate), an important precursor molecule for the dolichol-phosphate lipid carrier needed in the N-glycosylation reaction. | The [https://en.wikipedia.org/wiki/N-linked_glycosylation N-glycosylation]is a post-translational modification realized in the endoplasmic reticulum of the cell. This process consist in linking a glycan to a protein, which provide the biological protein fonction and folding. The hcis-PT produce DHDD (dehydrodolichyl diphosphate), an important precursor molecule for the dolichol-phosphate lipid carrier needed in the N-glycosylation reaction. | ||
- | |||
=== Disease comprehension === | === Disease comprehension === |
Revision as of 09:00, 15 January 2022
Heterotetrameric Cis-Prenyltransferase Complex
|